Phase II study of RPL 554 in patients with chronic obstructive pulmonary disease

Trial Profile

Phase II study of RPL 554 in patients with chronic obstructive pulmonary disease

Completed
Phase of Trial: Phase II

Latest Information Update: 22 May 2013

At a glance

  • Drugs RPL 554 (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 22 May 2013 Results presented at the 109th International Conference of the American Thoracic Society.
    • 10 Jul 2012 Status changed from not yet recruiting to completed, as reported by a Verona Pharma Annual Report (2011).
    • 01 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top